Alexion Access Foundation Grants
Private foundation · EIN 20-8963321 · IRS 990-PF filings through tax year 2025
- Total grants paid
- $276.6M
- Grants reported
- 11
- Median grant
- $18.1M
- Future commitments
- None reported
Giving by tax year
| Tax year | Grants paid | Amount |
|---|---|---|
| 2025 | 6 | $131.9M |
| 2024 | 5 | $144.8M |
Where Alexion Access Foundation gives
States of grant recipients reported on the foundation's 990-PF filings, by dollars received.
Largest reported grants
The biggest individual grants on file, as reported by the foundation to the IRS.
| Recipient | Location | Purpose | Tax year | Amount |
|---|---|---|---|---|
| VIALS OF STRENSIQ WERE DISTRIBUTED | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2024 | $70.4M |
| VIALS OF STRENSIQ WERE DISTRIBUTED | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2025 | $57.5M |
| VIALS OF ULTOMIRIS WERE DISTRIBUTED | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2025 | $52M |
| VIALS OF ULTOMIRIS WERE DISTRIBUTED | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2024 | $45M |
| VIALS OF SOLIRIS WERE DISTRIBUTED T | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2024 | $22.6M |
| VIALS OF SOLIRIS WERE DISTRIBUTED T | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2025 | $18.1M |
| VIALS OF KOSELUGO WERE DISTRIBUTED | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2024 | $3.6M |
| VIALS OF KOSELUGO WERE DISTRIBUTED | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2025 | $3.4M |
| VIALS OF KANUMA WERE DISTRIBUTED TO | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2024 | $3.1M |
| VIALS OF KANUMA WERE DISTRIBUTED TO | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2025 | $582K |
| VIALS OF VOYDEYA WERE DISTRIBUTED T | NEW HAVEN, CT | PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PRODUCT | 2025 | $121.2K |
How to apply
This foundation publishes application instructions on its latest 990-PF and does not report restricting giving to preselected organizations. See more foundations that accept applications.
- Contact
- ALEXION ACCESS FOUNDATION
- Address
- 100 COLLEGE STREET NEW HAVEN, CT, 06510
- Phone
- 2032722596
- LOBALACCESS@ALEXION.COM
- Deadlines
- NONE
- Application materials
- APPLICATION FORM
- Restrictions
- ELIGIBLE PARTICIPANTS IN THE ALEXION ACCESS FOUNDATION PROGRAM ARE GENERALLY REQUIRED TO MEET, AMONG OTHER THINGS, MEDICAL, INSURANCE AND FINANCIAL CRITERIA TO BE ELIGIBLE FOR SUPPORT.
About this data
Figures are aggregated from Alexion Access Foundation's IRS Form 990-PF electronic filings (2 filings on file, most recent tax year 2025). Totals reflect grants the foundation reported as paid, and can lag the current year because foundations file annually and often on extension. Source: IRS 990-PF e-file archive.